Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 29, 2026
Reporting Period: The filing references financial information for the three and twelve months ended December 31, 2025, and includes forward-looking statements for 2025 and beyond.
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained in Exhibit 99.1 (a press release dated January 29, 2026), which is incorporated by reference but not included in the text of this filing.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It indicates that such information is presented in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
- Outlook: The filing incorporates forward-looking statements relating to 2025 and beyond, as presented in the press release.
- Legal Status: The information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
- Management Commentary: Specific commentary is located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 29, 2026) for actual financial figures for the three and twelve months ended December 31, 2025.
- Verify the specific forward-looking statements and guidance for 2025 and beyond contained in the press release.
- Confirm the company's status as an emerging growth company (indicated as unchecked in the filing).